hg_135933.1

Basic information about the TSS

---

TSS ID: hg_135933.1 Species: human Chr: chr13		Start: 102845793 End: 102845813 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000651002.1 Distance: 18 GeneID: 2073 HGNC/MGI_ID: HGNC:3437 UniProt_ID: A0A494C113

Gene_name: ERCC excision repair 5, endonuclease Gene_symbol: ERCC5 Gene_synonyms: Gene_source: HGNC:3437

TATA-Box annotation

---

Distance to TSS:	-38
Nearest PromoterID:	NM_000123
Entrez ID:	2073
Nearest Unigene:	Hs.258429
Nearest Refseq:	NM_000123
Nearest Ensembl:	ENSG00000134899
Gene Name:	ERCC excision repair 5, endonuclease
Gene Alias:	COFS3|ERCC5-201|ERCM2|UVDR|XPG|XPGC
Gene Description:	ERCC excision repair 5, endonuclease
Gene Type:	protein-coding
CpG%:	0.085
GC%:	0.58209
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ERCC5 p2@ERCC5 p3@ERCC5 p4@ERCC5 p5@ERCC5 p7@ERCC5
Sample		p1@ERCC5	p2@ERCC5	p3@ERCC5	p4@ERCC5	p5@ERCC5	p7@ERCC5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.26	1.95	1.75	1.36	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	7.28	2.43	3.44	1.42	0.81	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	6.37	1.54	4.44	2.31	0.19	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.99	3.95	3.74	1.87	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	5.85	2.92	2.02	1.57	0.90	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	5.62	1.36	1.36	1.36	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.24	2.61	3.49	1.09	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.51	1.45	1.70	1.21	0.48	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.47	2.56	2.99	1.50	0.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.81	5.22	8.11	2.90	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	20.21	5.26	7.68	2.43	2.83	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.87	4.07	4.07	0.81	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	8.06	2.90	2.58	0.81	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.73	3.31	1.80	1.05	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.66	2.63	1.54	1.32	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.81	2.77	1.51	0.75	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	7.43	2.18	1.53	0.66	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.12	3.37	1.69	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	5.33	1.07	2.13	0.00	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.13	2.86	1.05	1.20	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.55	2.41	0.94	1.07	0.40	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	6.04	1.21	1.38	1.38	1.04	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	7.88	1.42	1.81	1.16	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	5.58	1.94	0.97	0.73	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	8.00	2.32	2.06	1.55	1.03	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.23	2.53	1.27	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.44	2.20	1.10	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	7.54	2.12	2.59	1.18	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	7.75	1.29	1.13	0.97	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	6.51	1.81	1.45	0.72	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.23	2.09	1.47	0.84	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	4.88	1.76	0.39	1.56	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	4.01	1.90	0.84	1.06	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.58	1.32	0.99	0.33	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	5.42	1.12	1.12	0.93	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	4.98	2.30	0.77	0.38	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.54	2.25	1.23	1.43	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	4.23	1.21	1.61	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	4.05	2.43	2.16	1.62	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.20	1.92	1.44	0.72	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.29	0.71	1.18	0.94	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.93	1.32	1.32	1.02	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.69	3.59	1.05	1.90	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	6.29	2.45	1.40	1.92	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	5.42	1.61	1.61	2.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	5.58	3.02	1.86	1.40	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.72	1.44	1.68	2.16	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	5.36	2.38	0.89	2.09	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.62	2.39	2.15	1.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.67	2.22	1.01	2.63	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.20	1.84	0.82	1.84	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.56	3.78	1.11	2.00	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	13.99	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.03	1.06	0.00	3.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.62	1.33	2.32	2.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	30.20	0.84	3.36	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	7.81	2.30	1.38	1.84	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.48	1.30	2.27	1.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	6.74	0.64	2.25	1.28	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	8.80	0.94	0.94	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.05	0.00	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.73	0.56	0.56	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	8.76	2.39	0.80	0.80	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	5.78	1.02	0.68	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.55	1.30	3.25	0.65	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.61	2.84	0.35	1.77	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	23.69	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	0.98	1.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.43	0.99	1.49	1.49	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	1.41	2.35	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	16.23	0.33	1.32	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.21	2.17	1.86	0.62	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.48	1.83	1.53	1.22	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	20.91	1.74	1.90	1.58	0.63	1.27
Adipocyte - breast, donor2	11327-117E4	17.33	1.28	1.28	0.96	0.48	1.28
Adipocyte - omental, donor1	11473-119C6	25.95	1.53	2.80	1.02	2.04	0.64
Adipocyte - omental, donor2	11474-119C7	14.95	1.49	0.75	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	14.40	1.34	1.00	0.67	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	19.14	0.64	0.00	0.64	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	23.03	3.61	0.90	2.26	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	10.95	1.04	0.87	0.70	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	21.32	3.72	2.15	1.17	0.39	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	17.76	0.77	0.77	1.03	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	18.12	1.95	1.67	1.67	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	19.40	3.53	1.18	0.59	1.18	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	25.58	2.65	3.62	1.45	1.61	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	21.62	1.94	1.94	1.94	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	9.60	2.13	1.60	1.60	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	21.14	1.67	2.78	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	20.38	1.25	2.91	2.91	1.25	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	16.33	1.00	1.51	1.26	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	16.36	1.64	1.96	0.98	1.64	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	11.57	3.35	0.30	0.91	0.91	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	2.65	0.22	0.22	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	0.36	0.72	0.36	0.72	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	8.64	0.18	0.90	0.36	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	0.00	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.11	0.00	0.82	0.00	0.62	0.21
Anulus Pulposus Cell, donor1	11248-116E6	22.20	2.17	1.14	1.37	0.57	0.11
Anulus Pulposus Cell, donor2	11463-119B5	12.98	2.94	1.22	1.71	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	7.64	1.35	0.90	1.35	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	13.89	0.43	0.87	1.30	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	2.14	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.06	1.79	1.49	0.30	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	5.06	1.26	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	3.30	0.66	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	9.42	2.92	0.65	0.97	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	8.74	3.40	0.49	0.97	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.13	1.19	1.78	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.43	3.39	1.51	0.75	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	8.71	0.73	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	1.25	2.51	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.86	1.65	1.48	1.32	0.49	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	1.36	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.84	1.51	0.30	1.66	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.04	2.68	2.14	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.12	1.89	0.38	0.94	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.36	3.47	0.80	1.07	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	2.93	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.80	0.33	0.50	0.66	0.17	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	0.00	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.40	1.72	0.69	1.20	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.68	1.46	0.97	1.46	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.76	2.28	0.38	2.28	0.76	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	0.00	0.00	0.00	1.21	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.11	2.28	1.14	1.14	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.41	1.28	1.07	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.52	2.58	1.55	0.77	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.91	3.28	0.00	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.68	1.93	0.96	1.93	0.32	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	0.71	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.02	3.51	2.34	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.53	0.90	1.51	1.51	1.20	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	2.38	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.10	1.53	0.51	2.03	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.66	0.76	0.76	0.25	0.25	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.81	1.27	0.64	1.27	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.18	2.16	0.86	0.86	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.89	0.64	0.21	1.06	0.85	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.22	0.87	0.00	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	3.78	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.31	0.85	0.34	0.85	0.85	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	2.11	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.93	1.72	0.21	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	0.60	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	7.29	3.64	0.73	1.46	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.82	3.22	0.69	0.46	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.15	1.02	1.02	0.76	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.35	2.27	0.41	1.45	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.51	1.22	0.61	0.00	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	13.38	0.48	1.43	1.91	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.20	1.55	1.11	0.67	0.22	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	0.00	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	1.66	1.66	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.33	1.06	0.00	0.79	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.72	0.73	0.36	1.09	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	6.39	1.11	0.49	0.74	0.12	0.12
Astrocyte - cerebellum, donor2	11580-120F5	4.45	1.37	0.51	0.17	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	1.68	0.42	0.21	0.63	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	11.85	1.39	3.49	0.70	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	14.24	3.40	1.94	2.10	0.97	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	14.47	2.24	1.64	0.89	0.45	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	54.70	3.67	2.06	1.61	1.38	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	38.71	3.01	1.50	2.51	1.00	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	44.38	1.71	2.39	1.14	1.59	0.46
Basophils, donor1	12241-129G9	25.11	5.49	2.62	2.62	0.00	0.00
Basophils, donor2	12242-129H1	73.60	4.69	3.25	2.53	0.72	1.80
Basophils, donor3	12243-129H2	21.17	4.56	1.18	1.18	0.44	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	4.31	0.22	0.65	0.43	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.11	0.46	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	0.63	1.26	0.00	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	3.33	0.83	0.42	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	9.44	0.46	0.69	0.23	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	13.14	0.36	0.36	0.54	0.90	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	26.18	0.93	0.93	2.27	1.13	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	38.89	1.63	1.86	1.63	0.70	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	31.66	4.80	4.16	1.28	1.28	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	20.29	4.51	1.13	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	23.94	4.27	1.48	2.04	0.00	0.56
CD14+ Monocytes, donor3	11381-118B4	22.83	3.51	3.29	1.54	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	47.27	3.68	1.70	3.40	1.70	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	55.72	5.31	3.41	1.90	0.76	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	41.09	2.63	1.97	1.97	1.31	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	24.28	3.90	1.73	4.34	1.59	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	16.60	5.13	2.11	1.21	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	22.27	5.21	2.61	1.90	0.95	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	8.87	1.84	0.84	1.51	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.94	2.76	0.83	2.21	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	9.67	3.72	0.74	1.24	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.44	4.11	0.78	1.96	0.98	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	9.61	3.56	0.71	2.49	0.00	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.10	1.52	0.00	1.96	0.22	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	8.66	4.45	0.23	1.17	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	19.01	4.75	1.06	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	21.08	5.55	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	13.54	4.61	1.34	1.64	0.45	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.98	2.20	0.80	2.39	0.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.28	3.12	1.04	1.67	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	9.61	3.43	1.14	2.29	0.46	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	14.70	2.04	0.68	0.68	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.17	4.36	0.87	2.62	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	13.45	2.96	0.81	2.42	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	16.57	4.36	2.09	1.05	0.52	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	16.83	3.37	1.68	1.26	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.14	2.57	0.37	1.65	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.28	0.35	0.00	1.41	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	7.02	1.32	0.00	0.88	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.07	4.88	0.70	2.27	0.35	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	3.72	1.86	1.86	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	16.38	4.74	1.08	2.80	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.91	0.41	0.00	2.46	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	10.20	2.09	0.46	2.32	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.35	1.86	0.00	2.78	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	47.30	3.71	2.62	2.18	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	40.19	6.47	1.62	2.54	0.69	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	38.77	5.20	1.30	2.82	1.08	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	53.57	7.16	4.36	2.65	0.47	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	51.00	5.24	4.72	4.02	0.52	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	72.02	6.47	3.79	3.34	1.34	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	37.00	7.91	3.06	3.06	0.77	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	42.16	9.44	4.39	1.76	2.63	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	52.00	7.58	3.16	4.42	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	48.78	8.13	6.10	8.13	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	63.05	10.17	2.71	6.10	0.68	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	53.85	7.25	3.11	5.18	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	75.16	12.79	6.40	6.93	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	69.69	8.58	5.90	6.43	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	74.41	9.83	2.81	8.42	0.00	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	72.94	3.92	7.84	3.92	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	68.55	5.27	2.64	9.23	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	49.31	12.33	5.75	4.93	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	29.74	9.43	3.63	2.90	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	35.84	8.08	2.52	3.03	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	56.57	3.23	5.25	6.06	1.62	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	44.34	4.79	2.40	0.80	2.00	1.20
CD34+ Progenitors, donor1	11545-120B6	21.09	1.00	3.01	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	23.03	1.69	2.81	1.12	2.25	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	38.70	5.64	3.38	1.88	4.13	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	46.00	2.71	2.03	1.13	3.83	0.00
CD4+ T Cells, donor1	11225-116C1	95.33	19.64	16.78	5.71	0.36	1.43
CD4+ T Cells, donor2	11306-117C1	73.48	20.21	16.53	4.90	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	60.08	13.42	13.42	6.40	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	86.27	10.72	5.87	4.34	1.02	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	79.28	6.51	4.27	4.49	0.45	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	81.64	6.32	5.75	5.46	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	131.32	46.94	30.82	6.16	0.95	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	134.85	38.63	30.90	7.73	0.70	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	85.70	32.96	23.07	9.89	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	88.59	5.78	5.78	3.47	0.43	1.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	51.69	6.10	7.29	3.90	0.68	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	50.46	5.48	6.45	3.06	0.32	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	100.42	26.90	14.35	4.48	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	97.13	20.26	9.78	4.89	0.35	2.45
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	144.31	13.20	15.40	5.28	0.00	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	104.99	4.64	10.12	3.79	0.84	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	52.15	4.36	2.91	2.91	1.45	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	44.10	3.34	6.01	4.01	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	147.93	32.90	19.04	7.07	0.00	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	175.79	32.16	25.19	11.25	0.00	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	118.35	35.86	26.90	8.97	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	85.85	6.49	7.60	3.34	0.37	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	58.27	5.85	5.85	5.85	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	72.92	5.67	11.14	4.20	0.00	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	93.03	19.72	10.62	2.53	0.51	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	89.68	16.90	13.00	3.03	1.30	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	155.59	19.18	8.72	8.72	1.31	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	110.36	15.84	11.38	7.92	0.99	2.97
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	121.86	11.08	12.00	10.16	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	104.69	16.75	12.56	6.98	4.19	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	149.54	18.55	11.91	9.14	2.49	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	213.49	18.40	14.23	10.06	1.47	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	113.96	16.94	21.56	6.16	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	145.75	13.61	9.67	8.24	1.79	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	123.26	8.31	11.08	9.69	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	75.63	11.79	12.44	3.27	0.65	0.33
CD8+ T Cells, donor2	11307-117C2	50.68	14.64	10.14	3.38	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	70.70	20.20	16.16	5.81	0.50	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.08	0.69	0.69	0.00	1.15	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	14.38	0.48	0.48	0.24	0.72	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	15.05	0.55	1.37	0.55	1.09	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	13.51	0.60	0.30	1.50	1.50	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	15.12	0.00	1.20	0.00	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.60	0.00	0.45	0.45	1.14	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	15.21	0.00	0.65	0.43	1.09	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.27	0.53	0.26	0.00	1.05	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.71	0.23	0.23	0.23	1.17	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	25.96	0.91	0.30	1.81	1.21	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	20.92	1.16	2.03	0.87	1.45	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	18.65	0.27	0.00	0.53	1.33	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	16.20	0.00	1.31	0.44	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.48	0.00	0.46	0.00	0.91	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.17	1.49	1.49	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	7.20	1.08	0.00	0.00	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.66	0.00	0.00	0.58	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	11.08	0.71	0.47	0.24	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	17.43	0.00	0.32	0.00	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.30	0.62	0.00	0.00	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.79	0.96	0.32	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	18.36	0.76	0.76	0.76	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	18.92	1.97	0.00	0.79	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.91	0.76	0.76	0.00	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	29.71	1.61	0.80	0.80	0.80	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.08	1.40	4.20	0.70	2.10	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	25.04	1.00	0.00	0.00	2.00	3.01
Cardiac Myocyte, donor1	11525-119I4	5.48	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.34	1.48	0.99	0.00	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	9.79	0.84	1.05	0.95	0.42	0.21
Chondrocyte - de diff, donor1	11261-116G1	19.07	0.69	0.69	0.69	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	14.57	0.36	2.49	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	11.49	1.71	1.71	0.46	0.68	0.11
Chondrocyte - re diff, donor2	11339-117F7	20.59	1.79	0.90	2.69	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	9.71	1.62	0.00	1.21	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	23.87	5.51	2.18	2.98	0.57	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	11.54	3.85	1.50	1.50	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	14.78	2.57	1.68	1.86	0.09	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	16.96	4.59	3.85	1.56	0.55	0.28
Corneal Epithelial Cells, donor1	11526-119I5	4.39	0.22	0.44	0.22	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.37	0.26	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	36.98	1.82	2.48	1.32	0.83	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	43.21	1.26	1.26	0.95	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	0.00	0.00	3.45	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.22	1.30	1.40	1.19	1.51	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	48.17	6.83	4.10	1.37	0.68	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	47.66	8.49	4.57	3.26	0.65	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	57.11	7.26	5.81	2.90	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	8.34	1.17	0.17	1.33	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	2.93	0.59	0.59	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	5.37	0.85	0.57	0.85	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	4.72	0.39	0.79	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	6.69	1.16	0.29	0.29	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	6.82	2.12	0.47	1.18	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	9.47	1.23	0.88	0.70	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.18	2.88	0.66	1.55	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	16.43	2.74	0.00	4.56	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	18.89	1.13	1.69	0.85	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	2.97	0.00	0.59	1.19	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	0.00	1.04	1.04	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	4.25	0.99	0.85	1.28	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	10.00	2.00	0.40	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	8.91	0.52	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	24.73	3.48	0.99	1.74	0.37	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	10.43	2.39	0.43	0.87	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	10.75	2.32	0.61	1.22	0.12	0.12
Endothelial Cells - Vein, donor1	11267-116G7	7.96	2.28	1.14	1.14	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	4.89	2.10	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	4.08	2.36	0.16	1.26	0.00	0.16
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	75.91	16.50	3.30	4.95	0.00	1.65
Eosinophils, donor3	12246-129H5	49.94	14.27	7.13	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	4.89	0.73	0.24	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	17.24	1.64	0.82	0.82	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.35	1.31	0.66	0.33	0.55	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.10	1.41	0.54	0.54	0.11	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.40	2.30	1.70	0.73	0.97	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	61.82	10.64	4.91	3.96	3.28	1.91
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.91	2.32	1.05	0.74	0.53	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	42.95	5.53	3.95	5.01	1.32	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.28	3.99	1.66	1.00	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	8.62	1.81	0.45	0.91	0.00	0.91
Fibroblast - Cardiac, donor2	11345-117G4	12.89	3.03	0.76	0.76	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.89	0.79	0.16	0.95	0.79	0.32
Fibroblast - Cardiac, donor4	11452-119A3	31.22	3.64	1.52	3.03	0.30	1.21
Fibroblast - Cardiac, donor5	11456-119A7	15.23	1.90	1.02	1.65	0.76	0.51
Fibroblast - Cardiac, donor6	11460-119B2	9.10	2.43	0.45	0.91	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	9.78	1.74	0.80	0.27	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	13.37	2.59	0.43	2.16	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	0.00	1.46	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	7.15	0.46	0.23	0.00	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	24.08	3.05	2.71	1.02	1.70	0.85
Fibroblast - Dermal, donor1	11269-116G9	16.20	2.11	1.17	1.88	1.88	0.23
Fibroblast - Dermal, donor2	11346-117G5	13.68	1.89	1.89	0.47	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	18.13	2.30	1.09	0.73	0.60	0.60
Fibroblast - Dermal, donor4	11450-119A1	15.60	2.37	0.79	1.02	0.68	0.11
Fibroblast - Dermal, donor5	11454-119A5	14.65	1.92	1.74	1.74	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	12.67	2.11	1.62	1.30	0.81	0.16
Fibroblast - Gingival, donor1	11237-116D4	29.36	1.87	1.87	1.25	1.87	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	29.08	2.10	2.10	0.52	1.05	1.05
Fibroblast - Gingival, donor2	11318-117D4	14.63	1.84	2.11	1.71	0.66	0.40
Fibroblast - Gingival, donor3	11394-118C8	22.72	3.29	2.51	2.13	0.97	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	2.08	0.00	1.04	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.86	1.06	1.23	0.35	0.88	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	24.94	2.65	1.87	0.62	0.47	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	21.64	1.76	1.49	2.16	0.81	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	4.94	3.18	2.12	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	15.94	1.75	1.17	0.88	1.61	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	26.18	1.64	1.77	1.77	1.64	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	14.15	2.19	1.65	0.66	0.55	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	17.46	3.37	3.23	2.64	1.17	1.17
Fibroblast - Lung, donor1	11270-116H1	5.44	1.36	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	0.00	2.98	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	10.76	2.11	0.84	0.63	0.21	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.84	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	9.34	0.81	2.03	0.81	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.79	2.33	2.52	0.39	0.58	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	21.08	3.49	1.37	2.12	0.76	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	44.67	1.53	3.98	3.06	1.22	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	16.03	1.14	1.91	0.38	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	10.80	1.08	0.54	0.54	1.35	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	11.02	1.97	1.86	1.28	0.70	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	12.27	1.77	0.44	0.88	0.66	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.92	0.81	0.20	0.41	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	1.34	1.34	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.86	1.19	1.19	1.58	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	50.21	3.97	2.18	3.57	5.56	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.72	1.42	3.55	1.95	2.13	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	23.26	1.77	2.56	1.77	0.59	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	33.39	3.31	3.61	3.01	4.81	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	28.72	3.35	1.94	1.40	1.84	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	54.41	3.29	4.05	2.78	2.28	1.27
Fibroblast - skin normal, donor1	11553-120C5	23.14	1.80	1.31	1.31	0.82	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	66.17	3.61	2.41	2.81	2.61	2.21
Fibroblast - skin normal, donor2	11561-120D4	25.22	1.51	1.00	0.80	1.00	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	54.70	3.63	6.95	2.42	6.65	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	21.54	1.99	1.91	1.08	0.41	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	33.85	3.93	2.74	1.88	0.85	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	53.21	1.64	3.28	2.96	2.96	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	26.42	1.81	1.49	0.75	0.64	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	18.55	1.35	1.52	1.01	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.33	0.94	0.31	0.16	0.63	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	22.66	4.36	1.74	0.87	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	16.82	2.77	1.73	2.25	0.69	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.78	1.56	2.08	1.82	1.82	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	16.61	4.34	2.56	2.56	0.51	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	2.30	0.77	3.06	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1.91	0.00	1.28	0.00	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	7.13	2.85	0.86	2.57	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	6.89	3.03	2.21	4.41	0.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	7.31	4.11	4.79	2.51	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	5.75	2.77	0.79	2.38	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	6.61	1.85	2.64	3.44	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	9.13	6.20	5.54	1.63	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	8.84	2.65	1.77	2.65	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	11.59	1.55	0.71	3.53	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	14.65	2.71	1.60	1.60	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	8.33	1.07	0.81	0.81	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	9.29	2.60	0.87	2.11	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	7.89	3.18	1.11	1.80	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	9.76	1.42	0.41	1.22	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	10.04	1.83	0.68	2.05	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	12.21	2.12	1.12	1.87	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	9.40	1.31	0.44	1.53	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	12.41	2.36	2.07	0.59	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	11.13	2.70	1.75	1.59	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	11.17	1.34	0.67	1.79	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	14.32	1.81	2.22	1.21	0.60	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	11.54	2.04	2.37	1.02	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	17.65	3.19	1.68	1.42	0.89	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.23	4.68	2.71	2.19	1.04	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.91	2.90	2.39	2.22	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	13.50	2.55	2.99	2.10	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.55	2.91	2.58	1.00	0.42	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	23.48	3.06	2.65	1.63	0.41	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	17.95	2.06	2.27	0.83	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	15.80	3.69	1.61	2.08	0.35	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	15.34	2.33	2.00	1.33	0.50	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.09	1.98	0.66	1.32	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	16.11	3.57	2.09	1.23	0.74	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	12.81	2.92	2.92	2.11	0.49	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	14.43	3.21	3.21	0.96	1.92	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	12.98	3.22	2.56	1.52	0.38	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	12.34	3.32	2.37	0.95	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	13.38	1.82	1.22	1.22	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	13.38	3.24	1.99	1.46	0.52	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	20.20	2.20	0.88	1.10	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	14.87	1.12	2.52	0.56	0.84	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.85	2.59	2.31	1.30	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	12.30	1.87	1.34	1.34	0.80	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	11.93	2.14	1.22	0.92	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	11.53	1.68	1.68	0.65	0.78	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.16	1.90	1.36	0.27	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.30	2.21	1.29	0.74	0.00	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	14.91	1.54	2.63	0.44	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	23.80	1.98	0.00	1.98	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	15.30	1.58	2.24	1.06	0.26	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.92	1.61	1.21	1.41	1.01	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	31.52	5.08	1.78	1.52	0.25	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	15.33	3.38	2.59	3.18	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	9.71	2.93	1.23	1.85	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	11.25	2.86	1.23	3.89	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	4.07	1.25	2.19	1.56	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.83	2.26	1.13	0.28	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	6.92	1.84	1.84	1.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	0.00	0.00	0.00	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	5.80	1.16	0.77	1.93	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	8.02	0.00	0.00	0.00	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	8.69	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	8.14	1.95	1.30	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	11.12	1.65	3.71	1.65	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	3.33	6.66	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	8.95	0.84	1.40	1.12	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	9.15	3.60	1.96	0.33	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.03	2.52	2.52	3.36	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	7.63	2.23	1.59	0.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	5.43	0.68	2.38	1.02	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	4.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.88	1.72	1.72	2.29	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	3.85	2.66	1.18	0.89	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	9.11	1.66	3.73	1.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	8.28	0.46	2.76	1.84	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	5.27	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	6.92	2.31	1.54	0.77	1.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.06	1.96	2.28	1.30	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.70	2.68	2.68	2.01	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.56	2.70	2.31	1.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	8.22	2.74	1.37	2.74	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	2.48	2.48	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	7.55	2.36	1.42	1.89	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.67	1.21	1.81	1.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	14.75	3.05	2.03	4.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	9.57	1.20	1.99	1.20	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	15.29	0.49	2.47	1.48	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	17.71	2.36	0.00	2.36	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.09	0.58	1.75	1.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	19.31	2.19	2.19	3.07	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	11.02	2.54	0.00	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	7.76	1.19	1.79	0.60	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	8.25	2.91	3.40	0.97	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	13.31	1.25	2.08	0.83	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	2.25	2.25	1.12	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	15.22	2.22	0.63	0.32	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.46	0.84	1.67	2.51	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	8.36	1.51	0.46	0.35	0.81	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.80	1.69	1.52	0.51	0.17	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	7.96	1.37	0.68	1.59	0.46	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	8.42	0.98	0.77	0.55	0.11	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	9.03	1.07	0.21	1.93	0.43	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	6.03	1.94	0.86	2.15	0.65	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	5.36	1.00	0.12	1.00	0.37	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.72	1.20	0.86	0.69	0.51	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	8.01	2.56	0.32	1.60	0.96	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.36	0.56	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1.73	0.43	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.00	0.00	0.00	0.71	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	0.00	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.89	0.87	0.35	0.70	0.52	0.17
Hepatocyte, donor1	11523-119I2	38.74	2.42	3.63	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	21.55	4.31	0.00	1.08	3.23	1.08
Hepatocyte, donor3	11684-122I1	27.61	1.84	1.23	1.23	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	25.45	6.53	10.44	1.96	1.96	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	27.09	5.07	1.40	2.27	0.70	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.86	2.61	1.10	1.65	0.14	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	18.00	2.77	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	2.50	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	1.67	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	1.32	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	6.65	1.11	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	5.24	0.00	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	0.63	1.89	0.00	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.27	1.29	1.29	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.07	0.00	1.63	0.81	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	10.50	0.84	0.84	0.84	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	9.64	0.00	0.00	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	10.16	0.92	0.00	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.66	2.36	0.94	0.47	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1.81	0.00	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	14.74	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	2.15	2.15	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	0.00	0.00	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.12	2.55	1.91	0.00	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	0.00	1.82	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.71	0.00	1.43	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.48	0.62	0.31	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	0.00	6.29	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	14.60	0.70	0.00	0.00	2.78	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.08	0.00	0.87	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	2.25	0.00	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	1.07	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	0.00	1.39	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	4.60	0.92	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2.11	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	23.91	3.02	1.06	1.39	1.55	0.49
Keratinocyte - epidermal, donor2	11349-117G8	5.27	1.17	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	14.96	1.99	0.95	0.57	0.66	0.28
Keratinocyte - oral, donor1	11251-116E9	33.15	2.72	1.82	1.70	1.82	0.45
Keratocytes, donor1	11527-119I6	6.88	1.38	0.34	1.38	0.34	0.00
Keratocytes, donor2	11607-120I5	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	14.62	3.36	0.79	0.59	0.99	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	11.87	2.16	1.08	3.24	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	12.11	2.08	1.85	1.50	0.35	0.00
Lens Epithelial Cells, donor3	11690-122I7	17.56	2.62	1.31	1.51	0.81	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.92	1.07	0.83	0.71	0.36	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4.47	1.12	0.56	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.65	2.52	1.73	0.31	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.99	2.15	0.54	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.41	0.32	0.32	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.77	0.54	0.86	0.86	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4.92	1.23	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.78	0.76	0.51	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5.21	1.55	0.42	0.56	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.49	0.00	1.58	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.72	1.36	0.39	0.58	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.15	0.37	0.19	0.00	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.92	1.74	1.05	1.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.25	0.72	0.24	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.22	1.10	0.55	0.82	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.47	1.54	0.31	0.92	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.68	0.94	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.49	0.73	0.00	0.55	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.58	0.66	0.33	0.33	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.51	0.88	0.00	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.98	0.25	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	0.97	0.48	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.46	0.81	0.00	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.42	1.06	0.45	0.45	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.67	1.04	1.04	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.54	1.68	0.21	0.84	0.84	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.06	0.90	0.30	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	2.06	0.69	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.96	2.26	0.56	0.56	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.14	0.42	0.32	0.21	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.18	1.45	0.48	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.96	1.32	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.21	0.50	0.50	0.37	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	13.33	2.59	1.48	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.18	0.99	0.49	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.22	1.10	0.14	0.14	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.22	2.57	0.32	0.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.04	1.52	1.22	1.52	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.84	1.12	0.42	0.70	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.76	0.71	0.36	1.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.85	0.48	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.87	0.47	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.37	0.36	0.36	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.53	0.65	0.33	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.77	1.18	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	11.39	1.61	0.74	0.87	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.59	0.26	0.51	0.51	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.37	0.90	0.60	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	6.90	0.77	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	17.07	1.48	1.48	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.04	0.85	1.27	0.42	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	0.00	0.70	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	9.34	0.00	0.00	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.24	1.03	1.03	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	0.00	1.19	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6.79	0.68	0.68	0.45	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.76	0.87	0.29	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.10	0.00	0.90	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.43	1.08	0.41	0.54	0.27	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.70	0.00	1.54	1.03	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	8.47	0.35	0.71	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.32	0.00	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.15	0.51	0.00	2.55	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	9.07	0.53	0.80	1.07	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.01	0.57	0.94	0.38	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.14	0.61	2.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	4.08	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.41	0.42	1.04	0.21	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	10.09	1.40	0.84	0.56	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	1.03	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	9.29	0.58	0.00	0.58	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	6.88	0.30	0.00	0.00	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.96	1.66	0.55	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	6.36	1.06	0.71	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.48	0.37	1.11	1.48	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	4.61	0.00	0.00	2.30	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	6.14	0.38	0.77	0.77	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	0.57	1.13	1.70	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	0.82	1.64	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	5.87	2.26	0.90	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	0.00	1.44	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.96	2.24	0.00	0.75	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.55	1.11	0.00	1.11	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.03	1.29	0.86	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	4.28	3.43	1.71	2.57	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.33	0.67	0.67	0.33	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	4.83	0.60	1.81	1.81	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.98	1.42	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.53	1.03	0.69	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.98	0.54	0.00	1.07	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.06	0.00	2.02	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	8.52	0.74	0.00	0.37	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	0.00	1.16	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	7.40	3.17	3.17	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	7.60	0.80	0.40	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	2.18	0.73	0.00	0.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	4.60	2.30	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	10.36	1.97	0.49	0.49	1.97	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	1.88	0.94	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	7.54	1.51	1.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	7.66	0.90	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	4.45	1.78	0.00	0.45	0.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.17	0.78	0.78	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.90	0.00	0.66	1.98	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	7.78	2.08	1.04	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	8.75	1.31	0.88	0.44	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5.59	0.00	0.56	1.68	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	6.62	0.00	0.44	0.88	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.94	1.54	0.39	0.77	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	5.57	1.01	0.00	1.01	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	4.81	0.96	1.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	5.57	1.59	0.40	0.80	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	10.33	1.82	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	7.61	0.69	2.08	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.26	0.38	1.52	0.76	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	10.33	0.52	0.52	0.52	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.26	0.60	1.21	0.00	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	6.97	0.00	0.32	0.32	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	6.93	1.60	1.60	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	6.32	0.57	0.00	0.57	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	6.69	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.24	0.00	1.41	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2.84	1.13	1.13	1.70	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	5.82	1.66	0.00	0.42	0.83	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	4.70	0.78	0.00	0.78	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.01	0.42	1.25	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.50	0.93	1.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	3.35	0.67	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	8.02	1.60	0.53	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	4.45	1.21	0.40	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	1.84	0.92	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	1.78	0.89	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7.98	0.00	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	5.37	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	6.02	0.00	0.55	3.28	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	3.56	0.45	0.89	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	7.02	1.04	0.26	0.26	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	4.64	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	32.14	1.82	0.91	0.91	1.14	0.46
Macrophage - monocyte derived, donor2	11313-117C8	22.20	0.92	0.92	0.73	1.10	0.00
Macrophage - monocyte derived, donor3	11389-118C3	21.50	1.31	1.31	0.66	0.52	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.68	2.12	0.00	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	28.36	2.22	1.74	1.74	1.27	0.63
Mallassez-derived cells, donor3	11930-125I4	22.93	2.78	0.83	0.97	0.42	0.56
Mammary Epithelial Cell, donor1	11273-116H4	32.18	1.20	1.20	1.20	4.19	0.80
Mammary Epithelial Cell, donor2	11350-117G9	28.95	0.58	0.87	0.87	2.03	0.58
Mammary Epithelial Cell, donor3	11422-118F9	8.48	2.74	0.25	0.50	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	109.15	7.46	0.68	1.36	0.68	4.75
Mast cell, donor1	11563-120D6	66.61	3.57	2.16	2.38	0.54	1.30
Mast cell, donor2	11565-120D8	79.05	5.65	2.38	2.38	1.49	0.59
Mast cell, donor3	11566-120D9	99.05	7.20	3.15	4.95	0.68	1.80
Mast cell, donor4	11567-120E1	77.48	5.14	2.66	3.19	0.71	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	66.20	3.99	2.22	2.88	1.44	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	76.46	2.92	2.33	2.33	0.58	1.75
Mast cell, expanded, donor5	11939-126A4	58.28	2.18	1.38	3.56	0.23	0.69
Mast cell, expanded, donor8	11941-126A6	68.12	4.85	2.34	3.01	0.50	2.01
Melanocyte - dark, donor1	11502-119F8	17.31	1.19	0.80	0.30	0.40	0.20
Melanocyte - dark, donor2	11582-120F7	14.54	1.38	1.38	0.00	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	23.25	2.03	1.59	0.43	0.94	0.29
Melanocyte - light, donor1	11274-116H5	6.58	0.47	0.71	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	13.65	0.68	1.36	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	2.60	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	9.37	2.19	0.62	1.35	0.31	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	12.37	1.08	1.08	0.54	1.08	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	17.41	2.14	0.80	1.07	1.07	0.54
Meningeal Cells, donor1	11493-119E8	6.20	0.99	0.87	0.87	0.00	0.00
Meningeal Cells, donor2	11573-120E7	8.36	0.88	1.32	0.44	0.44	0.00
Meningeal Cells, donor3	11654-122E7	15.65	2.20	1.63	1.06	0.73	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	15.40	5.42	0.57	1.71	0.86	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.33	4.73	1.31	1.41	0.91	0.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.74	2.15	0.72	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.92	0.42	0.85	0.21	1.06	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	15.58	3.52	0.50	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.93	0.22	1.32	0.22	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2.19	0.73	0.00	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.12	0.61	0.82	1.02	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.96	2.49	1.25	1.94	0.28	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.95	0.00	0.74	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	21.05	1.71	1.84	0.92	0.92	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.53	0.89	1.19	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.76	0.00	0.64	2.56	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	14.53	1.77	0.35	1.06	0.71	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	14.70	0.94	1.56	0.63	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	12.34	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	26.25	7.42	1.86	2.12	0.27	3.98
Mesothelial Cells, donor2	12156-128G5	17.02	4.50	1.00	0.00	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	16.91	5.78	1.23	1.45	0.65	1.30
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	10.80	1.35	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.41	1.23	0.99	0.00	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	22.67	1.18	1.18	2.36	0.88	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	20.77	1.24	1.55	0.31	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	20.33	1.04	1.66	0.41	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	18.02	2.00	1.50	1.50	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	24.20	0.93	0.47	0.93	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.51	1.63	0.81	0.61	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	22.57	2.38	0.79	1.58	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	16.34	0.38	1.14	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.73	0.64	0.85	1.06	1.27	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	0.00	0.92	0.92	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.54	0.89	1.19	1.49	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.29	0.75	1.00	0.75	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.26	1.66	0.48	1.43	0.71	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	0.55	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.74	0.46	0.00	0.69	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.83	0.63	0.63	0.42	0.63	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.13	1.02	0.20	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	11.16	0.64	0.00	1.07	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.78	0.89	0.44	1.11	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.57	0.88	0.00	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.55	0.00	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.25	1.09	0.27	0.27	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	1.18	0.00	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3.36	0.48	0.00	0.96	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.81	0.00	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	8.01	0.50	1.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.63	0.44	0.88	1.75	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	0.64	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	8.43	0.25	0.25	1.24	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	0.00	0.70	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10.60	0.68	0.00	0.34	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2.13	0.36	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	14.31	0.28	0.28	0.56	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	6.65	1.25	0.42	0.42	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.75	1.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.37	0.60	0.90	0.60	0.90	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	20.03	1.25	0.00	0.83	0.83	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	0.92	0.00	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.66	1.71	0.57	1.14	1.14	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	6.91	0.55	0.97	0.55	0.41	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.48	1.55	0.00	1.04	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	8.58	0.86	0.00	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.91	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.21	0.53	0.53	1.07	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	17.06	1.50	0.60	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.62	1.70	0.14	0.99	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.10	0.64	0.64	0.64	0.64	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.68	1.55	0.88	0.66	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	5.69	1.52	0.38	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	17.61	0.85	0.57	0.85	0.57	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	22.12	0.98	0.98	1.72	0.00	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	1.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	18.23	3.23	1.18	0.88	0.59	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	21.34	2.31	0.29	2.31	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	25.14	2.47	2.06	0.82	0.41	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	1.19	1.49	0.30	0.30	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	3.77	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	1.78	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	17.09	2.30	0.00	0.99	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	0.00	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.34	1.98	0.99	0.99	0.59	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.04	2.79	1.86	0.00	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	16.90	1.13	0.00	0.75	0.38	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	14.12	1.33	0.53	0.80	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	20.81	0.68	1.02	0.34	0.23	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.84	0.74	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.19	0.00	0.73	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	0.00	0.00	4.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	12.29	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	3.03	1.01	2.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	11.81	0.84	0.42	0.00	1.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	9.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	0.64	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	6.48	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	11.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	6.52	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	15.30	0.86	1.94	0.86	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	10.45	2.61	1.57	1.05	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.01	0.67	0.67	1.33	0.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.76	6.26	0.83	1.25	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	18.44	3.99	1.90	1.14	0.38	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	0.00	1.60	3.19	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.76	3.40	3.40	1.36	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	71.67	9.19	1.84	3.68	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.28	2.51	3.35	3.35	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.85	3.49	1.86	0.70	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.38	2.97	0.81	1.62	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.98	1.47	2.73	1.26	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	33.40	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.91	3.97	1.49	0.50	2.48	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.83	2.71	1.08	1.89	0.27	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.29	2.49	1.36	1.59	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3.43	2.94	1.47	2.29	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.49	3.28	2.55	2.37	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	8.49	3.71	3.71	2.12	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.60	6.60	2.40	1.80	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.72	3.28	0.66	0.98	0.66	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.34	2.44	0.49	0.65	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.46	3.00	1.59	2.12	0.71	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	10.55	1.41	1.41	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.03	3.22	1.38	2.76	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.85	5.14	2.57	2.25	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	19.31	4.83	1.03	1.72	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	58.15	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.13	2.23	1.56	0.45	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.50	0.85	1.27	0.42	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.78	2.85	1.42	1.19	0.71	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.44	3.86	1.29	0.43	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	9.03	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	5.66	4.67	1.33	1.33	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	3.61	1.35	1.80	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.94	2.78	1.98	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	0.00	0.93	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.81	3.78	1.89	0.38	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.87	3.26	1.63	1.30	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.92	2.61	2.61	1.31	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.40	4.07	0.45	0.00	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	4.41	2.65	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	6.65	1.33	2.66	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.94	3.47	1.49	1.49	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.59	1.53	1.91	0.77	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	21.17	7.56	0.91	2.12	0.60	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	14.59	2.43	2.43	1.11	0.44	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	5.42	4.07	2.03	2.03	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	0.00	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.15	7.32	1.22	2.44	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.24	3.46	2.83	2.52	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4.84	1.82	2.42	1.82	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	9.49	2.37	0.79	3.96	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	24.94	4.53	2.27	0.00	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	10.12	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	20.13	0.87	2.11	0.75	1.12	0.37
Myoblast, donor2	11322-117D8	21.86	2.30	1.73	1.92	1.92	1.15
Myoblast, donor3	11398-118D3	24.89	2.19	0.84	1.35	1.01	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	42.32	2.04	2.04	1.02	1.90	0.58
Natural Killer Cells, donor1	11230-116C6	69.81	9.84	12.30	1.85	0.31	0.92
Natural Killer Cells, donor2	11311-117C6	53.98	10.25	7.54	2.41	0.60	2.41
Natural Killer Cells, donor3	11387-118C1	67.73	13.25	8.65	3.31	0.74	1.47
Neural stem cells, donor1	11275-116H6	23.59	1.45	4.72	2.18	1.45	0.36
Neural stem cells, donor2	11352-117H2	26.96	3.85	11.55	0.00	1.93	0.00
Neurons, donor1	11494-119E9	11.38	1.14	1.14	2.28	1.14	0.00
Neurons, donor2	11574-120E8	12.11	5.94	4.84	3.08	0.22	0.00
Neurons, donor3	11655-122E8	9.04	4.93	3.29	1.64	0.00	0.82
Neutrophils, donor1	11233-116C9	55.68	15.78	1.86	2.78	0.93	0.93
Neutrophils, donor2	11314-117C9	23.19	5.80	0.00	2.90	0.00	5.80
Neutrophils, donor3	11390-118C4	86.13	44.59	6.72	3.05	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	22.08	2.37	2.49	1.19	1.19	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	13.02	2.93	0.65	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	6.82	1.40	0.20	1.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	9.22	1.38	1.51	0.83	0.96	0.69
Olfactory epithelial cells, donor2	11934-125I8	11.43	1.59	1.01	0.29	0.58	0.43
Olfactory epithelial cells, donor3	11935-125I9	11.80	0.79	1.25	0.57	1.14	0.34
Olfactory epithelial cells, donor4	11936-126A1	15.68	2.05	1.27	1.36	0.58	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	10.83	1.81	1.20	1.20	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	14.25	2.13	0.85	1.28	0.21	0.64
Osteoblast - differentiated, donor2	11353-117H3	4.57	3.43	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.31	0.62	1.24	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	5.08	1.17	0.59	0.20	0.39	0.20
Osteoblast, donor2	11354-117H4	14.75	2.81	1.40	4.21	0.70	0.70
Osteoblast, donor3	11426-118G4	8.35	0.89	1.78	0.53	0.89	0.53
Pancreatic stromal cells, donor1	11249-116E7	26.87	2.53	1.35	1.52	1.60	0.93
Pericytes, donor1	11491-119E6	3.89	0.67	0.22	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	2.72	0.45	0.91	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	3.66	0.00	0.61	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	19.67	1.36	0.90	0.90	0.57	0.34
Perineurial Cells, donor2	11579-120F4	23.37	1.84	1.20	1.01	0.18	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	90.20	13.07	7.33	2.87	0.96	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	35.75	11.02	4.65	1.71	0.73	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.47	12.42	6.47	2.20	0.52	0.78
Placental Epithelial Cells, donor1	11278-116H9	6.46	0.00	0.00	0.48	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	13.31	1.11	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	7.26	0.00	0.20	0.20	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	5.38	0.00	0.63	0.32	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	23.64	1.69	1.31	0.75	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	46.08	2.74	2.87	2.48	2.35	1.31
Preadipocyte - breast, donor2	11328-117E5	16.66	1.80	1.58	1.35	0.90	0.90
Preadipocyte - omental, donor1	11468-119C1	22.06	2.02	1.60	0.75	1.17	1.07
Preadipocyte - omental, donor2	11329-117E6	29.68	0.44	0.44	1.75	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	18.77	1.86	1.58	0.57	0.86	1.43
Preadipocyte - perirenal, donor1	11469-119C2	5.91	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.36	2.46	0.61	0.61	1.23	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	21.25	3.54	1.42	1.95	1.24	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	16.35	2.89	1.53	1.87	0.68	0.85
Preadipocyte - visceral, donor1	11280-116I2	43.13	5.22	2.33	1.86	1.68	1.21
Preadipocyte - visceral, donor2	11357-117H7	26.69	2.30	0.92	0.46	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	24.24	3.66	1.25	0.73	0.42	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	15.09	1.66	2.11	1.66	0.30	0.30
Prostate Epithelial Cells, donor2	11331-117E8	13.41	2.71	0.54	1.22	0.41	0.27
Prostate Epithelial Cells, donor3	11404-118D9	11.82	1.16	0.73	1.59	0.49	0.31
Prostate Stromal Cells, donor1	11254-116F3	12.64	1.59	1.25	0.68	0.91	0.80
Prostate Stromal Cells, donor2	11332-117E9	9.32	1.26	0.54	0.18	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	13.24	1.98	1.36	1.36	0.31	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.38	0.36	0.00	0.36	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	14.21	1.94	0.69	1.04	0.55	0.07
Renal Epithelial Cells, donor1	11517-119H5	0.00	0.00	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.13	0.71	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	13.23	2.43	1.48	1.06	1.06	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1.36	0.68	1.36	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	2.29	0.94	0.54	0.54	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	7.99	1.33	0.67	1.33	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	0.00	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	4.40	0.44	0.00	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.13	0.63	0.63	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	0.55	0.00	0.00	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	5.37	0.00	0.54	0.27	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.95	0.84	0.00	0.42	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	2.89	0.77	0.39	0.77	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	9.59	2.59	0.78	1.30	1.04	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.54	0.57	0.00	0.57	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.29	1.00	2.26	1.25	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	40.22	3.34	2.00	0.94	0.94	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	22.34	2.68	0.89	0.89	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	41.28	3.85	1.65	1.65	2.20	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	43.50	1.16	0.58	2.32	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	23.92	3.51	2.99	2.86	1.17	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	11.02	1.99	1.49	0.99	0.89	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	23.20	2.57	2.79	2.23	0.45	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	27.29	2.85	2.48	2.85	1.98	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	12.35	1.75	1.40	1.28	1.63	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	16.18	3.00	1.85	2.77	0.92	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.83	2.46	1.23	1.37	0.68	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	10.29	1.66	2.12	1.21	1.36	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	16.49	3.05	1.79	2.87	1.61	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.92	2.44	1.86	2.15	1.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	12.56	1.40	1.72	1.29	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	15.05	2.66	1.55	1.33	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	15.49	1.53	1.34	2.87	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	11.55	1.68	1.77	1.30	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.05	2.82	3.38	1.32	0.75	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	12.34	1.86	2.12	1.99	0.66	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	14.11	2.43	2.04	1.46	1.36	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	13.75	3.06	1.15	2.29	1.15	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.10	2.88	1.50	1.50	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.89	1.40	1.12	1.68	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	15.55	2.91	2.22	1.88	1.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	14.22	1.46	1.09	1.64	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	12.39	2.08	1.84	1.96	0.61	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	14.78	2.15	1.61	2.55	0.81	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	21.70	2.36	1.65	2.36	1.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	11.71	2.38	1.79	1.79	1.19	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	12.86	2.81	2.10	1.40	1.17	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	12.86	2.07	2.28	2.07	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.06	0.88	2.65	3.10	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	14.83	2.72	1.04	2.09	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	17.09	3.36	2.29	2.56	2.02	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	11.24	1.02	2.21	1.70	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	12.53	2.12	2.31	2.12	0.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	23.73	1.55	3.61	1.72	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	13.99	1.65	1.78	1.65	0.41	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	17.73	1.81	0.99	1.97	1.15	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.09	2.56	2.22	1.53	1.36	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	14.65	2.66	1.04	1.63	1.18	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	19.99	1.87	1.60	1.07	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	17.15	3.04	2.49	1.94	1.38	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	15.48	2.38	0.95	1.43	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	24.59	3.43	1.61	2.82	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	24.39	2.17	2.17	2.26	1.51	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	19.91	3.49	2.10	2.10	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.25	2.42	3.93	0.91	0.91	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.38	2.69	2.08	3.30	0.86	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	48.03	5.39	6.70	4.08	1.75	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	25.55	2.43	4.26	0.61	0.61	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	23.81	2.71	1.51	3.92	1.81	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	27.37	3.39	3.17	2.94	1.13	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	33.55	2.10	3.29	3.59	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	31.53	2.36	3.19	1.65	3.07	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	27.11	4.27	2.56	2.99	1.71	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	33.65	2.40	4.81	3.00	1.20	1.20
Schwann Cells, donor1	11498-119F4	3.20	0.94	0.56	0.19	0.19	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	12.27	1.75	0.88	1.10	0.44	0.44
Sebocyte, donor1	11220-116B5	11.50	1.10	0.00	0.00	0.55	0.55
Sebocyte, donor2	11301-117B5	6.89	0.92	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	5.98	1.03	0.21	0.82	0.21	0.21
Sertoli Cells, donor1	11255-116F4	23.19	0.00	1.66	0.00	3.31	0.00
Sertoli Cells, donor2	11333-117F1	14.12	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	10.56	1.85	1.23	1.58	0.44	0.18
Skeletal Muscle Cells, donor2	11358-117H8	4.34	0.72	0.00	0.72	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	5.85	1.67	2.51	2.51	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	17.75	3.14	1.73	1.26	0.79	0.31
Skeletal Muscle Cells, donor5	11455-119A6	16.50	2.23	1.34	1.64	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	13.24	1.69	0.77	0.62	0.46	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	49.02	2.52	2.77	2.27	2.27	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	24.54	2.71	1.71	0.57	0.86	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.84	2.18	1.98	1.59	0.79	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	18.96	3.12	0.84	1.26	0.42	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	2.90	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.37	1.38	0.69	0.41	0.55	0.00
Skin - palm, donor1	10286-104F7	10.74	2.69	0.00	2.69	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.78	1.15	0.43	1.01	0.58	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	103.05	6.54	4.09	15.54	8.18	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.75	0.39	0.52	0.26	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	20.16	1.53	0.83	0.97	0.97	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	10.55	1.41	0.98	1.83	0.56	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	87.33	5.29	4.86	4.65	3.59	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	12.37	1.27	0.60	0.97	0.60	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.11	0.93	1.23	1.54	0.62	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	35.13	5.56	2.22	1.78	2.67	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	15.28	1.76	1.76	1.18	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.61	0.88	0.66	0.88	0.00	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.06	1.97	0.79	0.00	1.97	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	14.68	0.77	0.77	1.55	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	16.01	1.00	4.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.04	1.60	1.06	0.93	0.80	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	20.17	1.99	0.89	0.44	0.44	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	18.95	2.30	1.66	1.02	0.90	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.65	2.60	1.30	1.95	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.31	1.18	2.07	1.48	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.39	1.99	0.71	1.14	0.57	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.63	0.65	0.00	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	13.09	1.83	1.83	1.83	0.61	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.91	3.54	2.02	1.52	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	0.48	0.00	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.30	2.65	1.62	2.06	0.88	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	12.05	1.29	0.43	1.29	0.43	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	11.55	2.73	2.10	1.47	0.63	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.22	2.17	0.46	0.77	0.62	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	4.31	1.08	0.00	0.00	3.23
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.97	2.39	0.60	0.00	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2.39	0.34	0.34	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	27.17	2.98	1.73	1.26	0.39	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	30.29	8.05	1.11	2.82	1.41	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.38	2.96	0.91	1.59	0.00	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.64	0.60	0.60	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	12.19	2.38	1.59	0.79	0.79	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.70	1.86	2.00	1.60	1.86	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.53	1.75	2.13	1.38	0.50	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.22	2.03	1.78	0.51	2.54	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	23.22	3.62	1.06	1.36	1.21	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.00	0.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1.29	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	14.88	2.79	1.86	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.56	2.52	1.01	0.50	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	14.10	1.57	1.25	0.94	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.88	0.59	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	16.74	2.25	2.17	0.92	0.67	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.01	0.93	0.47	1.87	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.21	1.30	1.01	0.58	1.15	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	6.37	0.51	0.25	1.53	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.21	0.56	0.56	0.56	0.75	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	26.83	2.38	1.96	2.24	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	14.66	1.93	0.67	1.09	0.25	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.90	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	8.07	2.20	0.98	0.24	0.49	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.87	2.21	2.65	1.77	1.55	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	17.55	2.05	0.59	0.29	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.63	2.72	0.97	1.36	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.26	2.12	1.32	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	30.50	1.86	2.23	1.49	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	19.40	5.03	2.52	1.80	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	12.49	2.56	0.57	1.42	1.42	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.24	2.36	0.79	1.58	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	16.25	0.76	1.02	2.29	1.27	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	13.18	3.59	1.20	2.00	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	12.54	0.42	0.84	0.84	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	14.67	1.38	3.67	2.75	0.92	0.46
Synoviocyte, donor1	11291-117A4	15.49	1.18	1.35	0.34	0.67	0.00
Synoviocyte, donor2	11368-117I9	17.27	1.68	1.01	1.51	0.34	0.67
Synoviocyte, donor3	11440-118H9	14.52	2.68	1.12	0.45	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	5.00	1.07	0.36	1.07	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	3.24	0.69	0.69	1.16	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	12.19	1.22	0.57	0.36	0.79	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	6.19	0.77	0.00	0.39	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	6.87	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	41.95	3.57	3.20	2.34	1.23	1.35
Urethra, donor2	10319-105A4	5.40	3.60	3.60	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	5.31	0.53	0.00	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	2.40	1.20	0.40	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.52	0.23	0.23	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	27.42	1.11	1.56	0.45	1.56	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	102.33	7.12	2.67	5.34	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	82.92	8.58	5.72	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	41.76	7.53	2.05	1.37	0.68	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	76.44	5.17	4.13	3.44	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	93.55	1.16	4.07	2.91	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	67.68	2.08	0.00	2.08	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	85.35	9.18	3.67	9.18	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	35.60	2.74	4.56	1.83	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	8.27	1.23	0.74	0.25	0.37	0.12
Wilms' tumor cell line:HFWT	10597-108E3	0.88	0.00	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	25.98	2.51	3.07	3.63	1.12	0.00
achilles tendon, donor2	10292-104G4	8.27	4.13	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	41.56	5.10	3.82	4.08	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	35.75	1.86	2.79	2.09	1.63	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	33.59	6.29	4.51	5.82	0.59	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	38.37	9.25	6.53	3.27	1.90	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	23.89	5.62	2.25	0.56	1.69	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	41.03	1.27	1.90	1.06	2.54	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	31.30	1.91	1.63	1.36	1.36	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	25.12	2.64	1.76	2.20	1.76	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	104.54	6.53	3.27	2.86	5.72	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	46.60	3.88	6.21	1.94	3.11	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	43.06	4.05	3.68	2.39	2.76	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	35.10	7.80	3.90	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	37.41	1.39	0.93	0.93	0.70	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	49.97	4.92	4.66	2.85	1.55	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	48.51	2.92	2.92	1.75	0.88	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	31.60	2.32	1.39	0.46	1.86	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	92.94	6.58	4.52	5.35	2.47	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	14.12	1.53	1.84	2.15	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	31.58	2.13	2.13	1.28	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	42.76	1.82	1.52	4.25	3.64	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	38.75	2.17	2.89	2.65	2.65	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	31.85	2.00	0.89	1.56	1.11	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	15.01	1.67	2.00	2.00	1.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	1.86	0.00	0.00	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	47.08	3.77	2.26	4.90	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	41.00	3.05	2.18	0.44	2.62	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	41.24	3.75	1.87	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	17.90	0.00	0.71	0.71	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	28.39	2.64	2.33	1.86	1.86	0.00
adipose, donor1	10184-103D4	17.59	2.35	1.76	1.76	0.00	0.00
adipose, donor2	10185-103D5	5.27	3.65	3.24	1.62	0.41	0.00
adipose, donor3	10186-103D6	7.08	2.72	3.81	1.91	0.54	0.00
adipose, donor4	10187-103D7	6.07	0.87	0.87	2.60	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	7.58	1.26	0.95	0.95	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	42.56	1.20	0.67	1.60	2.27	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	14.29	1.07	1.07	1.43	1.07	0.00
amniotic membrane cells, donor1	12235-129G3	24.11	1.16	1.16	0.93	0.93	0.70
amniotic membrane cells, donor2	12236-129G4	23.33	3.04	1.35	0.34	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	28.58	0.29	0.59	1.47	1.18	0.88
amygdala - adult, donor10196	10167-103B5	15.42	3.56	3.56	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	24.33	5.47	6.29	1.22	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	7.75	2.90	3.87	2.58	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	17.57	6.88	1.27	2.04	0.64	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	11.47	0.88	1.32	1.10	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	9.35	2.34	1.34	2.67	0.67	0.00
aorta, adult, pool1	10052-101G7	13.53	3.53	1.37	2.35	0.98	0.39
appendix, adult	10189-103D9	27.56	6.99	1.16	0.78	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	40.93	1.38	2.75	3.44	1.72	0.34
artery, adult	10190-103E1	14.95	4.08	5.43	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	21.87	3.19	3.91	1.30	1.59	0.43
b cell line:RPMI1788	10427-106D4	54.13	1.64	1.78	1.34	1.64	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	22.20	1.94	2.22	0.28	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	9.03	1.49	0.99	1.89	0.89	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	15.90	2.18	1.67	0.17	0.67	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	34.11	1.12	1.12	0.00	2.80	0.56
bladder, adult, pool1	10011-101C2	27.92	4.56	1.96	1.96	0.98	0.33
blood, adult, pool1	10053-101G8	31.00	8.86	2.21	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	19.70	0.86	0.00	0.00	1.71	0.00
bone marrow, adult	10192-103E3	21.59	0.00	3.37	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	9.23	2.05	2.05	2.05	0.00	1.03
brain, adult, pool1	10012-101C3	18.49	3.01	5.12	1.11	2.00	0.45
brain, fetal, pool1	10085-102B4	0.00	5.34	2.67	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	5.29	0.66	0.99	0.66	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	24.22	1.50	1.25	0.87	0.87	0.25
breast, adult, donor1	10080-102A8	18.31	1.89	0.63	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.15	0.76	0.89	1.40	0.25	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	12.99	2.16	2.47	0.62	1.86	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	20.03	1.15	0.92	1.61	3.22	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	41.40	1.94	3.63	1.69	5.81	0.48
carcinoid cell line:NCI-H1770	10703-109H1	32.44	2.82	1.41	1.88	5.17	0.47
carcinoid cell line:NCI-H727	10735-110B6	9.63	0.77	0.66	0.77	0.22	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	8.56	2.54	0.95	0.63	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	12.51	3.19	2.66	3.46	0.53	0.27
caudate nucleus - adult, donor10196	10177-103C6	21.88	4.61	3.45	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	22.76	3.35	10.21	0.67	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	14.52	4.58	8.41	0.76	3.06	0.00
caudate nucleus, newborn, donor10223	10354-105E3	7.69	2.93	7.32	1.10	0.00	1.10
cerebellum - adult, donor10196	10173-103C2	55.35	2.91	14.57	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	47.40	14.52	16.65	2.56	3.42	0.43
cerebellum, adult, pool1	10083-102B2	20.35	6.55	8.97	1.03	1.03	0.00
cerebellum, newborn, donor10223	10357-105E6	46.50	7.47	13.28	5.81	2.49	0.83
cerebral meninges, adult	10188-103D8	12.61	1.76	3.53	0.25	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	3.65	1.46	4.39	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	25.59	3.31	5.18	1.01	2.73	0.14
cervical cancer cell line:ME-180	10553-107I4	22.37	0.83	1.33	0.99	1.66	1.16
cervix, adult, pool1	10013-101C4	30.55	6.82	3.36	1.57	0.73	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	11.84	3.76	4.60	1.95	1.67	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	3.92	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	20.13	1.37	3.11	1.74	1.86	0.12
choriocarcinoma cell line:SCH	10785-110H2	10.97	1.72	1.60	0.99	0.49	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	6.40	1.42	0.95	0.95	0.95	0.00
chorionic membrane cells, donor1	12238-129G6	19.66	1.71	1.42	0.57	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	26.85	1.89	1.69	0.89	1.69	0.70
chorionic membrane cells, donor3	12240-129G8	29.12	1.10	0.55	0.55	1.65	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	17.17	4.04	2.02	1.01	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	20.55	1.73	2.31	1.15	0.77	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	41.39	2.32	0.63	1.06	2.32	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	15.66	0.77	0.00	1.54	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	15.00	0.48	0.97	1.21	1.45	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.77	1.63	1.22	1.02	0.81	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	16.49	2.36	0.00	1.77	1.18	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	67.24	2.61	1.82	1.56	4.69	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	17.37	2.74	2.74	1.14	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	6.59	0.52	1.39	0.52	0.52	0.17
colon carcinoma cell line:CACO-2	10513-107D9	14.64	2.01	0.73	0.92	0.73	0.00
colon carcinoma cell line:COLO-320	10420-106C6	47.13	6.84	7.60	4.56	2.28	1.90
colon, adult, donor1	10082-102B1	16.66	0.00	1.19	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	45.12	4.11	1.88	1.76	1.41	1.06
colon, fetal, donor1	10070-101I7	25.96	3.09	0.62	1.24	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	45.84	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	40.79	0.85	3.40	2.55	3.40	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	41.20	0.60	0.91	1.36	3.77	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	43.57	1.69	1.27	1.13	3.67	0.56
corpus callosum, adult, pool1	10042-101F6	29.63	5.20	7.08	2.21	1.66	0.11
cruciate ligament, donor2	10295-104G7	12.97	2.43	0.00	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	9.63	3.21	2.41	0.80	0.00	0.80
diencephalon, adult	10193-103E4	13.44	1.92	2.88	0.72	1.68	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	28.47	0.92	2.07	2.07	0.69	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	22.31	0.77	2.31	0.77	2.31	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	8.91	1.69	0.24	0.96	1.44	0.00
ductus deferens, adult	10196-103E7	37.87	3.99	6.48	1.99	1.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	21.60	5.76	7.20	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	40.46	2.94	3.68	1.47	1.47	0.74
dura mater, adult, donor1	10041-101F5	36.75	6.52	3.72	2.97	1.24	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	16.43	3.11	2.44	1.33	2.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	6.16	0.86	2.58	2.01	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	8.63	1.23	2.47	1.23	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	8.48	1.51	0.91	0.30	1.82	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	5.56	1.54	0.62	0.62	1.54	0.00
embryonic pancreas cell line:2C6	10603-108E9	7.88	1.31	2.63	1.31	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	6.03	1.01	1.68	0.00	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	10.69	2.54	1.45	1.99	1.63	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	5.47	0.80	0.48	1.45	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	39.57	2.89	2.89	1.67	1.33	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	15.18	2.42	1.10	2.20	0.99	0.55
epididymis, adult	10197-103E8	36.21	3.35	4.81	2.51	1.05	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	11.18	0.35	0.71	0.00	1.42	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	6.29	1.18	0.79	0.79	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	25.69	2.10	1.18	1.83	1.83	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	21.95	1.48	2.17	1.67	1.87	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	22.97	2.13	1.12	2.13	2.02	0.11
esophagus, adult, pool1	10015-101C6	23.78	4.67	1.70	1.27	0.42	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	14.53	2.76	3.38	1.88	0.50	0.50
eye - muscle inferior rectus, donor1	10272-104E2	14.49	4.83	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	4.21	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	7.44	2.98	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	10.32	2.29	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	8.74	2.91	0.00	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	17.03	3.31	1.53	2.54	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	10.39	3.21	1.03	1.15	0.64	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	9.26	1.66	0.47	1.19	1.19	0.00
frontal lobe, adult, pool1	10040-101F4	27.87	4.41	10.41	2.16	2.35	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	39.93	4.80	2.40	5.40	2.70	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	17.65	0.55	0.55	0.46	0.91	0.09
gall bladder, adult	10198-103E9	29.70	2.90	2.41	1.93	0.97	0.48
gamma delta positive T cells, donor1	11937-126A2	124.01	12.35	9.13	6.44	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	81.79	11.20	10.46	3.36	1.87	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	14.36	1.27	0.63	0.00	1.48	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	27.47	2.32	1.93	1.16	1.93	0.00
gastric cancer cell line:AZ521	10549-107H9	12.46	1.15	1.64	1.31	0.66	0.49
gastric cancer cell line:GSS	10560-108A2	10.98	0.92	0.92	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	31.76	8.45	6.63	2.28	1.60	0.00
giant cell carcinoma cell line:LU65	10487-107B1	9.29	1.95	1.49	3.90	0.57	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	17.91	2.38	1.82	2.10	0.56	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	20.70	1.75	1.75	1.00	2.24	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	9.39	2.22	2.53	2.43	0.42	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.55	1.54	2.95	2.25	0.42	0.14
glioblastoma cell line:T98G	10485-107A8	17.77	2.10	0.99	1.88	0.99	0.11
glioma cell line:GI-1	10413-106B8	17.28	2.93	2.34	2.34	1.76	0.00
globus pallidus - adult, donor10196	10175-103C4	19.68	3.64	6.56	1.46	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	36.86	7.57	7.81	1.22	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	13.69	2.74	10.95	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	11.19	3.20	3.20	1.07	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	56.28	4.89	2.45	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	10.93	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	11.84	1.60	0.96	0.96	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	8.72	0.92	1.84	0.92	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	11.89	0.91	0.91	0.91	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	10.95	2.58	1.93	1.29	0.00	0.00
hIPS, biol_rep1	14380-156B6	8.62	0.00	0.00	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.23	2.06	0.00	1.37	0.00	0.00
hIPS, biol_rep3	14382-156B8	11.03	1.10	7.72	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	42.24	3.16	1.15	0.86	2.01	0.29
heart - mitral valve, adult	10205-103F7	14.65	3.89	1.20	0.30	0.30	0.90
heart - pulmonic valve, adult	10206-103F8	23.27	1.83	4.45	0.26	1.31	0.26
heart - tricuspid valve, adult	10207-103F9	14.99	4.16	2.50	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	8.16	1.63	0.61	0.41	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	11.07	1.70	1.70	0.85	0.43	0.00
heart, adult, pool1	10016-101C7	10.81	3.68	1.84	1.15	0.46	0.00
heart, fetal, pool1	10046-101G1	31.21	5.54	4.83	1.54	1.03	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	12.65	1.23	1.23	0.31	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	1.19	1.19	2.38	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	13.48	0.88	1.55	0.55	0.66	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	17.36	0.61	2.06	1.09	1.21	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	16.17	2.02	1.52	0.30	0.61	0.51
hepatoma cell line:Li-7	10484-107A7	10.90	1.22	3.00	0.33	0.11	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	30.25	2.61	1.61	1.51	1.21	0.40
hippocampus - adult, donor10196	10169-103B7	23.66	1.89	2.84	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	23.68	5.92	6.33	0.82	0.82	0.82
hippocampus, adult, donor10258	10374-105G5	17.93	1.00	5.48	2.49	2.99	0.00
hippocampus, newborn, donor10223	10363-105F3	9.16	0.70	5.99	1.76	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	12.82	2.44	1.22	2.44	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.30	1.57	0.98	2.75	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	7.36	2.29	0.51	2.29	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.02	2.82	2.26	3.38	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	5.68	1.55	1.29	1.55	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5.31	0.38	0.76	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	10.22	3.21	2.34	2.63	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	14.22	3.02	4.74	2.59	0.43	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	9.59	2.92	6.67	3.75	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	10.66	1.42	2.60	2.84	1.18	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	8.68	2.41	3.70	2.25	0.96	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.77	0.67	2.02	2.69	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	7.35	2.50	0.94	2.66	0.47	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.88	4.42	0.49	3.93	0.49	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.96	2.62	0.87	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	11.45	2.67	2.86	3.05	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	8.29	3.49	2.62	2.18	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	9.50	0.00	3.00	4.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	10.55	4.14	3.58	2.26	1.13	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	14.55	5.00	2.27	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.84	4.07	3.76	3.76	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	9.63	3.27	4.41	2.61	0.98	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.90	1.16	3.19	1.45	0.87	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	9.57	4.18	3.29	1.49	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	8.31	2.59	0.55	1.48	0.55	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	7.70	2.00	1.14	3.14	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	10.21	1.22	0.41	2.45	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.51	3.17	2.46	2.82	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.65	1.58	2.53	2.22	0.63	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6.66	2.72	1.51	3.03	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	5.69	1.03	2.59	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	8.63	2.66	5.31	0.66	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	9.49	1.80	3.33	1.54	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	12.53	1.79	3.58	1.02	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	17.42	4.54	8.33	3.03	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	11.76	2.35	4.70	1.34	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.28	0.24	0.72	3.62	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	6.24	1.78	1.34	3.12	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	6.34	5.37	0.49	1.95	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	7.95	2.14	0.92	3.36	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	42.29	3.25	6.51	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	10.59	1.99	1.65	2.98	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	13.14	5.47	1.64	2.74	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	11.58	5.07	5.43	2.53	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	12.10	5.34	3.91	3.91	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	13.13	1.19	4.77	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	14.36	3.79	5.69	3.25	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	4.85	2.16	2.16	1.08	0.27	0.00
immature langerhans cells, donor1	11904-125F5	18.89	0.97	1.21	1.21	1.21	0.00
immature langerhans cells, donor2	11905-125F6	11.88	2.38	2.38	2.38	0.00	0.79
insula, adult, pool1	10039-101F3	26.40	3.41	9.27	1.89	1.61	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	22.44	2.28	3.58	0.98	1.95	1.30
kidney, adult, pool1	10017-101C8	21.73	2.80	1.80	1.20	1.30	0.40
kidney, fetal, pool1	10045-101F9	26.17	4.95	3.54	1.63	0.99	0.64
large cell lung carcinoma cell line:IA-LM	10509-107D5	34.09	6.25	3.27	1.56	1.99	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	6.64	0.69	1.24	0.55	0.41	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	4.77	1.47	1.28	0.55	0.18	0.00
left atrium, adult, donor1	10079-102A7	8.17	2.18	2.18	0.54	3.27	0.00
left ventricle, adult, donor1	10078-102A6	8.09	1.52	1.52	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	5.20	0.27	1.37	0.55	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	12.21	1.44	1.08	0.36	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	9.24	1.09	0.54	1.09	1.09	1.09
leiomyoma cell line:15425	10571-108B4	13.11	1.70	1.46	0.49	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	1.05	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	20.31	0.94	0.47	0.12	0.83	0.47
liposarcoma cell line:KMLS-1	10782-110G8	19.06	2.03	2.50	1.72	0.62	0.31
liposarcoma cell line:SW 872	10726-110A6	29.85	5.24	6.70	2.68	3.53	0.24
liver, adult, pool1	10018-101C9	28.52	3.40	2.27	1.94	0.81	0.32
liver, fetal, pool1	10086-102B5	1.88	0.94	2.82	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	16.33	3.21	3.06	0.29	1.02	0.15
locus coeruleus, adult, donor10252	10165-103B3	26.94	4.06	4.98	0.92	1.48	0.00
locus coeruleus, adult, donor10258	10375-105G6	9.03	3.10	3.39	0.56	0.85	0.00
locus coeruleus, newborn, donor10223	10362-105F2	21.45	3.36	5.05	1.26	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	10.79	0.55	0.55	0.14	1.25	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	17.24	0.69	0.00	1.38	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	19.11	2.37	1.32	0.79	1.05	0.53
lung, adult, pool1	10019-101D1	31.30	2.95	1.65	1.18	1.30	0.35
lung, fetal, donor1	10068-101I5	71.07	5.14	4.00	3.71	1.71	0.57
lung, right lower lobe, adult, donor1	10075-102A3	23.37	3.67	2.75	2.75	0.00	0.00
lymph node, adult, donor1	10077-102A5	27.93	2.84	3.31	1.89	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	17.10	1.10	1.75	1.10	0.66	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	18.41	2.57	1.66	2.57	0.75	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	26.33	5.95	2.55	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	25.75	4.00	4.00	0.44	0.44	0.44
mature adipocyte, donor2	12232-129F9	31.13	3.11	2.28	1.04	2.49	1.45
mature adipocyte, donor3	12233-129G1	30.82	1.66	1.90	1.19	2.84	0.00
mature adipocyte, donor4	12234-129G2	47.38	2.63	5.00	0.79	4.21	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	10.96	2.14	2.38	1.43	1.91	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	19.18	1.13	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	26.30	5.33	5.70	1.84	1.66	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	11.75	1.91	5.08	0.32	2.22	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	21.75	2.13	2.99	0.00	0.85	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	16.03	4.39	3.71	0.51	2.03	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	28.23	6.79	7.43	0.21	1.27	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	0.00	43.06	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	8.97	3.23	3.59	1.08	0.72	1.08
medulla oblongata - adult, donor10196	10174-103C3	18.17	2.60	3.89	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	27.56	3.72	6.19	1.24	0.46	0.00
medulla oblongata, adult, pool1	10038-101F2	21.30	3.84	5.06	1.31	0.90	0.16
medulla oblongata, newborn, donor10223	10361-105F1	14.93	3.12	3.47	1.04	1.39	0.69
medulloblastoma cell line:D283 Med	10838-111E1	29.23	9.30	8.41	3.99	1.33	0.00
medulloblastoma cell line:ONS-76	10759-110E3	2.81	0.98	0.37	0.12	0.24	0.00
melanoma cell line:COLO 679	10514-107E1	8.77	0.86	0.86	0.00	0.86	0.72
melanoma cell line:G-361	10465-106H6	13.84	0.81	2.44	0.00	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	10.13	1.99	1.09	0.72	0.72	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	20.27	5.29	4.41	2.64	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	9.33	3.37	3.89	4.41	1.30	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	24.70	1.99	1.07	1.53	1.38	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.63	2.54	1.09	0.73	0.91	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	28.16	0.83	1.24	1.66	1.66	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.00	4.07	1.26	1.83	0.98	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.91	4.04	1.54	1.35	0.39	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.82	2.78	1.39	2.78	0.00	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	12.70	2.92	1.20	1.37	0.69	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	17.60	4.26	1.15	0.58	0.46	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.45	1.72	1.33	0.66	0.93	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	15.80	3.11	1.08	1.22	0.95	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	18.78	3.70	0.85	0.85	0.85	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.50	1.98	1.32	1.98	0.99	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	15.36	2.63	0.69	1.38	0.42	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	30.72	4.54	2.09	0.35	1.05	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.40	2.25	1.63	1.22	0.61	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.18	3.59	1.80	0.72	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.41	4.55	1.55	1.66	0.52	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	20.29	6.61	1.82	0.46	0.68	2.05
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	37.76	5.87	2.10	2.10	0.42	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	16.74	2.24	2.09	1.20	1.49	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	14.88	3.85	0.70	1.49	0.70	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.46	3.31	1.84	1.84	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.74	2.29	0.57	0.86	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.53	1.26	1.68	0.00	1.68	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.07	1.83	0.00	0.91	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	14.84	1.28	0.77	0.00	0.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	18.58	1.31	1.05	1.05	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	16.33	2.16	1.54	0.92	1.23	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.24	1.41	2.35	0.71	0.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.91	0.68	1.35	1.02	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.97	1.18	1.96	1.18	1.57	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.51	0.93	0.93	1.85	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	20.48	2.02	0.58	1.44	0.58	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	18.74	1.56	1.78	0.45	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.34	0.72	1.92	0.72	0.48	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	21.27	4.40	1.47	2.20	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	17.45	2.01	1.01	1.01	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.92	1.23	0.82	2.05	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.32	1.29	0.43	0.86	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	5.47	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	10.33	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.86	2.27	1.95	1.95	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	2.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.19	1.60	2.67	1.60	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.90	1.64	0.00	2.45	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	11.27	0.78	0.00	0.78	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	0.00	4.20	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	2.98	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.82	1.78	0.59	1.19	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	20.27	2.53	0.63	0.63	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.04	0.34	0.34	0.69	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	2.15	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.04	0.81	0.41	1.22	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	0.79	0.79	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	8.84	0.59	1.18	1.77	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.09	0.31	1.56	0.94	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	16.04	2.67	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	2.37	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	0.00	5.14	2.57	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.28	2.07	1.38	0.69	2.07	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.92	1.98	3.96	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	1.12	1.12	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	13.36	3.82	4.45	1.91	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.07	1.21	1.61	2.01	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	4.36	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.78	1.21	3.03	0.00	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	4.52	9.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	11.53	2.47	2.47	0.82	4.12	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	14.88	0.79	0.60	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.30	1.30	1.62	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	0.00	1.02	2.04	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	20.12	1.55	2.32	0.00	3.09	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	11.34	1.18	1.89	1.42	0.71	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.99	3.48	0.46	0.70	0.93	3.71
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	4.27	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	13.15	0.21	0.41	0.51	0.41	0.92
mesothelioma cell line:Mero-25	10850-111F4	4.54	1.36	1.13	0.00	0.45	0.45
mesothelioma cell line:Mero-41	10851-111F5	10.76	0.49	0.73	1.47	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	13.51	2.44	1.77	1.33	1.11	0.44
mesothelioma cell line:Mero-82	10853-111F7	8.41	0.79	0.79	0.53	1.05	0.53
mesothelioma cell line:Mero-83	10854-111F8	13.28	1.36	1.19	0.68	1.19	0.00
mesothelioma cell line:Mero-84	10855-111F9	6.57	1.26	0.76	1.01	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	12.84	2.48	1.45	0.83	0.62	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	14.41	2.32	1.66	1.49	1.16	0.33
mesothelioma cell line:NCI-H226	10846-111E9	12.31	1.09	1.27	0.90	0.54	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	18.45	2.39	1.02	1.37	0.34	0.85
mesothelioma cell line:NCI-H28	10845-111E8	22.14	2.80	0.76	3.05	1.53	1.53
mesothelioma cell line:No36	10857-111G2	9.13	1.63	1.63	0.65	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	7.59	1.63	1.08	1.90	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	38.96	1.92	1.54	2.11	0.96	0.00
migratory langerhans cells, donor2	11902-125F3	28.21	0.98	0.73	2.08	0.49	0.12
migratory langerhans cells, donor3	11903-125F4	30.69	1.08	1.97	1.79	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	14.04	0.98	0.98	0.98	1.31	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	10.38	0.85	1.27	0.00	1.27	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	8.52	1.38	0.23	0.69	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	21.50	1.33	0.95	1.14	1.71	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	28.64	3.88	1.48	2.59	1.66	0.37
myeloma cell line:PCM6	10474-106I6	37.16	2.97	1.58	0.79	1.58	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	8.62	0.51	0.51	0.00	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	10.00	0.98	1.96	0.78	1.18	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	13.82	1.89	1.56	0.67	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	14.56	1.54	0.44	0.51	0.51	0.07
nasal epithelial cells, donor2	12227-129F4	15.46	1.66	2.21	0.00	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	20.25	8.05	16.10	2.07	2.07	0.46
neuroblastoma cell line:NB-1	10539-107G8	23.39	3.55	4.12	2.62	1.31	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	6.12	1.90	5.27	1.05	0.84	0.42
neuroblastoma cell line:NH-12	10555-107I6	23.67	6.71	9.13	3.17	1.49	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	17.08	1.66	4.27	0.24	0.00	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	12.83	2.85	3.80	1.58	0.63	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	8.25	2.42	2.42	1.01	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	8.26	9.54	2.54	1.27	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	9.85	1.60	0.53	0.00	0.80	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	130.90	7.61	2.88	6.93	1.86	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	11.21	1.60	2.40	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	11.54	0.96	1.28	1.92	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	13.93	1.05	0.00	0.53	1.05	0.00
nucleus accumbens, adult, pool1	10037-101F1	22.59	5.44	9.09	1.87	1.50	0.19
occipital cortex - adult, donor10196	10172-103C1	12.36	4.12	8.24	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	27.64	5.10	8.05	0.81	0.81	0.54
occipital cortex, newborn, donor10223	10355-105E4	9.10	4.00	2.18	0.73	0.36	1.46
occipital lobe, adult, donor1	10076-102A4	11.02	3.67	4.99	1.57	1.31	0.00
occipital lobe, fetal, donor1	10073-102A1	16.73	10.30	10.30	1.72	0.86	0.43
occipital pole, adult, pool1	10036-101E9	12.46	2.68	3.86	1.02	0.95	0.47
olfactory region, adult	10195-103E6	19.11	2.67	6.50	0.57	1.15	0.57
optic nerve, donor1	10277-104E7	12.01	2.00	10.01	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	23.35	3.08	2.62	6.04	1.48	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	27.48	3.85	1.79	1.65	1.51	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	20.15	4.23	2.20	1.69	1.52	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	16.86	1.27	1.50	1.04	1.27	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	9.41	1.18	0.59	0.00	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	22.42	3.74	0.00	1.87	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	14.21	1.48	3.82	2.97	0.64	1.06
ovary, adult, pool1	10020-101D2	17.73	6.03	2.71	2.01	0.44	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	7.15	1.47	0.73	0.37	1.10	0.18
pancreas, adult, donor1	10049-101G4	14.11	2.82	1.88	5.64	2.82	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	6.15	0.00	0.84	0.56	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	6.81	0.68	0.17	0.51	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	15.56	2.15	1.16	0.83	0.66	0.00
paracentral gyrus, adult, pool1	10035-101E8	22.42	2.93	6.96	1.37	1.83	0.55
parietal cortex, adult, donor10258	10373-105G4	22.02	5.87	5.87	2.94	2.20	0.73
parietal lobe - adult, donor10196	10171-103B9	10.35	4.70	2.82	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	22.52	7.41	3.99	0.57	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	19.39	3.97	5.29	0.97	1.76	0.09
parietal lobe, fetal, donor1	10072-101I9	18.43	8.73	5.82	8.73	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	15.33	1.87	2.99	2.62	1.50	0.75
parotid gland, adult	10199-103F1	25.90	1.85	5.55	0.62	0.00	0.00
penis, adult	10200-103F2	17.72	4.83	3.22	1.07	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	10.97	0.56	0.56	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	16.75	1.46	1.17	1.75	0.73	0.15
pineal gland - adult, donor10196	10179-103C8	34.83	3.23	5.16	0.65	4.52	0.00
pineal gland, adult, donor10252	10160-103A7	46.19	8.88	17.17	2.37	2.37	0.00
pineal gland, adult, donor10258	10377-105G8	23.20	1.88	4.39	1.88	3.14	0.00
pituitary gland - adult, donor10196	10180-103C9	41.48	10.12	9.11	5.06	2.02	2.02
pituitary gland, adult, donor10252	10162-103A9	65.15	7.82	15.11	3.13	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	40.01	4.26	11.92	5.11	4.26	0.85
placenta, adult, pool1	10021-101D3	25.26	1.83	0.86	1.83	0.11	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	27.54	3.18	2.38	1.32	0.79	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.14	2.65	1.87	2.80	0.16	0.31
pons, adult, pool1	10033-101E6	23.84	4.05	6.11	1.20	2.67	0.09
postcentral gyrus, adult, pool1	10032-101E5	15.78	3.92	5.75	0.61	1.31	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	4.18	2.09	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	5.51	0.00	5.51	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	9.03	1.02	0.29	0.87	1.02	0.29
prostate cancer cell line:PC-3	10439-106E7	11.80	1.09	2.00	1.27	0.18	0.36
prostate, adult, pool1	10022-101D4	23.04	3.99	2.45	2.36	1.00	0.36
putamen, adult, donor10196	10176-103C5	22.19	4.25	8.73	0.71	0.94	0.00
putamen, adult, donor10252	10152-102I8	23.53	3.92	7.84	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	12.02	0.00	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	13.77	1.69	6.52	1.93	2.17	0.97
putamen, newborn, donor10223	10365-105F5	19.49	4.50	2.25	3.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	28.22	1.45	2.04	1.45	1.16	0.58
rectum, fetal, donor1	10067-101I4	19.47	1.39	1.39	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	31.59	3.39	2.12	1.70	2.97	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	35.21	1.66	0.41	1.24	2.07	0.41
retina, adult, pool1	10030-101E3	25.35	5.27	4.37	0.80	1.19	0.10
retinoblastoma cell line:Y79	10475-106I7	14.81	4.16	4.16	0.78	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	7.99	0.74	1.84	0.25	0.25	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	12.09	3.94	2.81	1.69	0.56	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	11.37	1.52	2.27	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	23.31	1.13	0.49	0.97	0.65	0.81
salivary acinar cells, donor2	11772-123I8	21.07	2.48	1.38	1.24	0.41	0.55
salivary acinar cells, donor3	11773-123I9	15.89	3.31	1.99	0.00	0.66	0.66
salivary gland, adult, pool1	10093-102C3	29.74	5.15	3.43	2.86	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	27.99	7.17	3.04	2.70	1.52	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	28.33	5.88	2.94	3.17	1.29	0.94
seminal vesicle, adult	10201-103F3	33.33	5.82	3.17	1.06	0.53	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	26.96	1.46	1.46	1.21	0.73	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.28	0.50	0.50	1.26	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	2.01	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	5.91	1.34	0.94	1.34	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	15.58	1.33	1.33	1.22	1.99	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	29.80	0.90	1.16	1.16	1.16	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	2.84	0.71	0.71	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	15.83	4.92	2.40	0.72	0.48	0.12
skeletal muscle, fetal, donor1	10066-101I3	5.03	3.02	1.01	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	40.71	0.00	6.79	0.00	13.57	0.00
skin, fetal, donor1	10065-101I2	20.20	1.89	4.42	1.26	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	16.34	4.00	3.00	5.34	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	16.08	4.41	2.21	0.32	0.95	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	16.19	7.71	1.73	4.82	1.16	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	19.45	1.65	2.14	1.98	1.65	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	43.43	5.79	4.66	1.29	0.64	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	14.60	0.22	1.96	0.22	0.87	1.31
small intestine, adult, pool1	10024-101D6	60.92	3.22	1.67	2.03	1.67	0.84
small intestine, fetal, donor1	10064-101I1	23.10	0.74	0.98	0.49	0.98	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	21.54	2.05	0.51	1.54	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	21.45	2.07	1.03	0.78	0.78	0.78
somatostatinoma cell line:QGP-1	10781-110G7	6.16	0.27	0.54	0.80	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	12.85	3.90	2.98	0.92	0.46	0.23
spinal cord, adult, donor10252	10159-103A6	35.09	9.07	5.13	0.39	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	33.90	2.08	2.77	2.77	2.08	0.69
spinal cord, fetal, donor1	10056-101H2	10.98	6.71	2.44	3.66	2.44	0.00
spinal cord, newborn, donor10223	10359-105E8	32.14	4.13	5.97	0.92	1.84	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	8.21	1.19	0.90	0.15	0.75	0.30
spleen, adult, pool1	10025-101D7	38.33	3.63	3.52	2.42	0.55	0.55
spleen, fetal, pool1	10044-101F8	29.32	2.07	2.78	1.75	1.11	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	41.20	1.97	2.69	2.07	1.55	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	34.75	3.61	2.47	1.90	3.23	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	11.18	1.40	1.40	0.00	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	14.46	2.74	1.17	0.78	1.56	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	22.96	1.91	3.71	0.68	3.15	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.51	0.85	0.42	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	16.50	0.85	0.00	0.85	0.00	0.85
stomach, fetal, donor1	10062-101H8	17.09	3.20	1.07	1.07	2.14	0.00
submaxillary gland, adult	10202-103F4	30.76	7.41	2.85	1.71	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	27.42	5.19	3.95	0.62	1.87	0.00
substantia nigra, adult, donor10258	10371-105G2	17.07	3.62	6.72	1.03	2.07	0.00
substantia nigra, newborn, donor10223	10358-105E7	20.49	6.36	3.53	2.83	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	14.90	3.67	4.13	1.83	2.75	0.23
temporal lobe, adult, pool1	10031-101E4	12.97	2.71	5.00	1.27	1.70	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	9.97	6.41	8.55	4.99	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	12.31	3.96	4.40	2.64	0.88	0.44
tenocyte, donor1	11763-123H8	19.55	0.70	1.05	1.40	1.40	0.35
tenocyte, donor2	11765-123I1	14.88	1.91	1.91	1.53	0.00	0.38
tenocyte, donor3	11768-123I4	17.42	1.48	0.74	1.11	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	10.88	2.89	1.19	1.87	0.51	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	9.09	3.08	2.62	1.39	0.62	0.62
teratocarcinoma cell line:PA-1	10807-111A6	3.25	0.77	0.77	0.77	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	8.76	2.54	1.40	1.14	0.76	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	16.64	0.38	1.13	3.03	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	13.52	1.09	1.09	0.65	0.44	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	13.35	4.56	1.30	2.93	0.65	0.00
testis, adult, pool1	10026-101D8	16.00	6.44	4.94	1.93	1.72	0.21
testis, adult, pool2	10096-102C6	16.24	2.71	5.86	1.80	1.35	0.45
thalamus - adult, donor10196	10168-103B6	16.56	1.10	3.31	1.10	2.21	0.00
thalamus, adult, donor10252	10154-103A1	28.91	5.94	6.25	0.94	0.78	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	36.95	1.54	4.62	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	6.26	1.48	3.79	1.15	1.15	0.00
thalamus, newborn, donor10223	10366-105F6	12.08	0.58	1.73	0.58	0.58	0.00
throat, adult	10209-103G2	23.72	3.00	3.25	1.50	1.25	0.00
throat, fetal, donor1	10061-101H7	20.42	5.48	4.27	1.22	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	10.14	3.18	4.37	0.60	0.60	0.40
thymus, adult, pool1	10027-101D9	57.16	8.95	6.16	5.47	0.70	0.40
thymus, fetal, pool1	10043-101F7	77.20	9.77	7.07	6.03	0.62	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	19.81	2.53	0.93	1.73	1.33	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	10.62	1.40	1.82	0.42	0.84	0.14
thyroid, adult, pool1	10028-101E1	27.06	5.60	2.61	1.87	1.49	0.47
thyroid, fetal, donor1	10060-101H6	19.51	2.11	3.69	1.32	0.53	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	18.61	1.86	1.86	0.93	3.02	0.47
tongue, fetal, donor1	10059-101H5	13.79	1.58	3.15	0.79	0.79	0.00
tonsil, adult, pool1	10047-101G2	45.58	4.81	3.11	2.70	0.80	0.40
trachea, adult, pool1	10029-101E2	26.01	2.37	1.80	1.80	0.98	0.57
trachea, fetal, donor1	10058-101H4	24.24	4.23	3.46	1.54	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.98	1.42	1.77	0.35	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	13.98	3.65	1.52	2.33	1.52	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	15.83	1.41	0.78	0.47	1.10	0.31
tridermal teratoma cell line:HGRT	10694-109G1	5.71	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.96	2.03	1.35	1.95	1.69	0.17
umbilical cord, fetal, donor1	10057-101H3	4.17	0.00	8.35	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	37.20	7.85	3.24	2.22	0.68	0.17
uterus, fetal, donor1	10055-101H1	17.41	2.05	1.54	2.56	1.02	0.00
vagina, adult	10204-103F6	9.05	1.94	3.88	0.00	0.65	0.00
vein, adult	10191-103E2	27.40	3.73	4.82	2.63	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	27.24	1.34	0.53	0.53	0.80	0.00